VERGONI, Anna Valeria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.064
EU - Europa 2.893
AS - Asia 2.716
SA - Sud America 414
AF - Africa 39
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 4
Totale 13.144
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.008
GB - Regno Unito 1.320
CN - Cina 965
SG - Singapore 839
SE - Svezia 397
HK - Hong Kong 395
BR - Brasile 347
IT - Italia 287
DE - Germania 194
RU - Federazione Russa 168
UA - Ucraina 152
TR - Turchia 137
VN - Vietnam 132
FI - Finlandia 120
KR - Corea 73
BG - Bulgaria 61
FR - Francia 49
LT - Lituania 29
AR - Argentina 27
IN - India 27
CA - Canada 26
JP - Giappone 22
BD - Bangladesh 21
MX - Messico 20
ID - Indonesia 19
NL - Olanda 19
BE - Belgio 18
ZA - Sudafrica 18
IE - Irlanda 17
AU - Australia 14
ES - Italia 14
PL - Polonia 14
RO - Romania 14
IQ - Iraq 12
MY - Malesia 10
CL - Cile 9
EC - Ecuador 9
AE - Emirati Arabi Uniti 8
PK - Pakistan 7
VE - Venezuela 7
CO - Colombia 6
EG - Egitto 6
NP - Nepal 6
TW - Taiwan 6
AZ - Azerbaigian 5
IR - Iran 5
MA - Marocco 5
CH - Svizzera 4
HN - Honduras 4
IL - Israele 4
JO - Giordania 4
PY - Paraguay 4
AT - Austria 3
KE - Kenya 3
KZ - Kazakistan 3
SA - Arabia Saudita 3
AO - Angola 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EU - Europa 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
PE - Perù 2
TN - Tunisia 2
UY - Uruguay 2
UZ - Uzbekistan 2
XK - ???statistics.table.value.countryCode.XK??? 2
BO - Bolivia 1
BT - Bhutan 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
RS - Serbia 1
SV - El Salvador 1
TH - Thailandia 1
Totale 13.144
Salva come PNG Salva come JPEG
Città #
Southend 1.015
Santa Clara 714
Singapore 493
Chandler 491
Ashburn 487
Fairfield 473
Woodbridge 399
Hong Kong 388
Jacksonville 327
Hefei 325
Houston 301
Ann Arbor 294
Dallas 261
Chicago 242
Nyköping 242
Dearborn 211
Seattle 208
Wilmington 188
Cambridge 166
Los Angeles 166
London 139
Beijing 134
Salt Lake City 103
Modena 87
Izmir 76
Seoul 66
Moscow 63
Princeton 63
Sofia 60
Eugene 56
New York 54
San Diego 54
Helsinki 52
Elk Grove Village 49
Shanghai 49
Ho Chi Minh City 48
The Dalles 48
Council Bluffs 44
Tampa 40
Buffalo 34
Hanoi 33
Redwood City 30
São Paulo 30
Bremen 27
Columbus 27
Des Moines 27
Munich 25
Lancaster 21
Fremont 20
Falls Church 19
Dublin 17
Tokyo 17
Brussels 16
Guangzhou 16
Milan 16
San Jose 16
Sterling 16
Boardman 15
Detroit 15
Nanjing 14
Phoenix 14
Rio de Janeiro 14
Dulles 13
Frankfurt am Main 13
Jakarta 12
Norwalk 12
Turku 12
Orem 11
Stockholm 11
Brooklyn 10
Kansas City 10
Kent 10
Kunming 10
Miami 10
Philadelphia 10
Pittsburgh 10
Atlanta 9
Belo Horizonte 9
Denver 9
San Mateo 9
Sydney 9
Toronto 9
Haiphong 8
Hounslow 8
Johannesburg 8
Kilburn 8
Paris 8
Rome 8
Verona 8
Warsaw 8
Auburn Hills 7
Central 7
Chiswick 7
Hangzhou 7
Indiana 7
Jersey City 7
Montreal 7
Amsterdam 6
Manchester 6
Mexico City 6
Totale 9.494
Salva come PNG Salva come JPEG
Nome #
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 444
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 430
Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution 369
Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution 356
Similarities and differences between chronic migraine and episodic migraine 351
Effect of late treatment with gamma-hydroxybutyrate on the histological and behavioral consequences of transient brain ischemia in the rat. 339
CCAP regulates feeding behavior via the NPF pathway in Drosophila adults 295
Neuroprotective effect of L-DOPA co-administered with the adenosine A(2A) receptor agonist CGS 21680 in an animal model of Parkinson's disease 285
Peptide-engineered polylactide-co-glycolide (PLGA) nanoparticles for brain delivery of drugs: in vivo experiments and proof of concept 282
Regulation of hypothalamic endocannabinoid levels by neuropeptides and hormons involved in food intake and metabolism: insulin and melanocortins 262
Afferent vagal fibres and central cholinergic mechanisms are involved in the TRH-induced reversal of haemorrhagic shock 261
Cholecystokinin peptides and bombesin reverse hemorrhagic shock in rats 254
Brain effects of melanocortins 254
Glycopeptide-decorated nanoparticles as drug carriers for CNS: effects of surface coverage and carbohydrate type 253
Nanoparticles for brain delivery of drugs: in vivo experiments andmechanism of BBB crossing 249
INFLUENCE OF ACTH-(1-24) ON INGESTIVE BEHAVIOURS 246
Effect of repeated administration of prolactin releasing peptide on feeding behavior in rats 244
Effect of acute and chronic treatment with triiodothyronine on serotonin levels and serotonergic receptor subtypes in the rat brain 241
Anatomia chimica e funzionale dei sistemi peptidergici. 234
Health risk assessment of environmental selenium: Emerging evidence and challenges (Review) 233
Adhesion GPCRs are widely expressed throughout the subsections of the gastrointestinal tract 231
Putrescine has antiarrhythmic effects in rat models of arrhythmia. 225
Nanoparticles for brain delivery of drugs: in vivo experiments and mechanism of BBB crossing 221
BRAIN ACETYLCHOLINE IS INVOLVED IN THE ACTH-INDUCED BEHAVIORAL SYNDROME IN RATS 220
Engineered polylactide-co-glycolide(PLGA) Np as drug delivery systems for the Central Nervous System 218
Oral delivery of insulin loaded into polymeric nanoparticles in rats. 215
Brain MC4 receptors are involved in the melanocortin-induced hemorrhagic shock reversal, in rats 212
Energy gradients for VT-signal migration in the CNS: studies on melanocortin receptors, mitochondrial uncoupling proteins and food intake 209
New perspectives in peptides- and antibodies- conjugated nanocarriers for brain delivery therapeutic purposes 209
Sistemi anti-analgesici endogeni 207
Modified PLGA Nanoparticles as drug carriers for CNS delivery 205
Surface decorated nanoparticles as drug delivery agents to the brain 204
Characterization of the resistance to the anorectic and endocrine effects of leptin in obesity-prone and obesity-resistant rats fed a high-fat diet 204
Streptozotocin-induced diabetes provokes changes in serotonin concentration and on 5-HT1A and 5-HT2 receptors in the rat brain 204
Receptor heteromerization in adenosine A2A receptor signaling: Relevance for striatal function and Parkinson's disease 202
Polymeric nanoparticles for CNS drug delivery: strategies and perspectives 202
NPY-induced inhibition of male copulatory acivity is a direct behavioural effect 200
Influence of clonidine on the ACTH-induced behavioral syndrome 198
Mechanism of action of the anti-shock effect of CCK-8: influence of CCK antagonists and of sympatholytic drugs 197
A 7-DAY I.V.C. INFUSION OF ACTH-(1-24), IN RATS, IS ASSOCIATED WITH THE DEVELOPMENT OF TOLERANCE TO ITS BEHAVIOURAL EFFECTS AND WITH INCREASED LEVELS OF HYPOTHALAMIC B-ENDORPHIN 194
Nanoparticelle polimeriche per il direzionamento di farmaci al Sistema Nervoso Centrale 193
Peptide-decorated nanoparticles as carriers for drug delivery to CNS 192
Engineered nanoparticles for drug delivery to the CNS: in vivo experiments 191
Neuroprotective effect of gamma-hydroxybutyrate in transient global cerebral ischemia in the rat 190
Evidence that melanocortin 4 receptor mediates hemorrhagic shock reversal caused by melanocortin peptides 190
Chronic treatment with polychlorinated biphenyls (PCB) during pregnancy and lactation in the rat: Part 2: Effects on reproductive parameters, on sex behavior, on memory retention and on hypothalamic expression of aromatase and 5alpha-reductases in the offspring 187
Leptin-conjugated nanoparticles as drug delivery system to the brain 186
Chronic i.c.v infusion either of a melanocortin agonist or of an antagonist at low doses profoundly modifies energy balance without any other behavioral effects, in rats 185
Anti-shock effect of CCK-8 mechanis of action 184
Effetti periferici degli oppioidi 181
Anti-shock effect of ACTH-(1-24): comparison between intracerebroventricular and intravenous route of administration 179
Evidence that melanocortins are physiological antagonists of opioids 178
Peptide-derivatized nanoparticles as carriers of drugs into the central nervous system 174
Functional role, structure, and evolution of the melanocortin-4 receptor 173
Endogenous antagonists of opioid peptides 164
Nanoparticles and Brain Targeting 135
Differential influence of a selective melanocortin MC4 receptor antagonist (HS014) on melanocortin-induced behavioral effects in rats 119
Inhibition of feeding by ACTH-(1-24): behavioral and pharmacological aspects 100
LACK OF INFLUENCE OF AROMATASE AND 5-ALPHA-REDUCTASE INHIBITION ON [H-3] IMIPRAMINE BINDING IN THE MALE-RAT BRAIN 3
PINACIDIL POTENTIATES MORPHINE ANALGESIA 2
l-Sulpiride, at a low, non neuroleptic dose, prevents conditioned fear stress induced freezing behavior in rats 2
OPENING OF BRAIN POTASSIUM-CHANNELS INHIBITS THE ACTH-INDUCED BEHAVIORAL SYNDROME IN THE MALE-RAT 1
REPEATED ADMINISTRATION OF TRIIODOTHYRONINE ENHANCES THE SUSCEPTIBILITY OF RATS TO ISONIAZID-INDUCED AND PICROTOXIN-INDUCED SEIZURES 1
EFFECTS OF THYROID STATUS ON THE CHARACTERISTICS OF ALPHA1-IMIPRAMINE, ALPHA2-IMIPRAMINE, BETA-IMIPRAMINE IMIPRAMINE AND GABA RECEPTORS IN THE RAT-BRAIN 1
INFLUENCE OF GONADOTROPIN-RELEASING-HORMONE ON CASTRATION-INDUCED DEPRESSION IN MICE - A BEHAVIORAL AND BINDING STUDY 1
INFLUENCE OF THE SELECTIVE CHOLECYSTOKININ ANTAGONIST L-364,718 ON PAIN THRESHOLD AND MORPHINE ANALGESIA 1
NO MODIFICATIONS OF GABA(A) AND BENZODIAZEPINE RECEPTORS FOLLOWING EXPERIMENTAL DYSTHYROIDISM IN RATS 1
Corticotropin-releasing factor (CRF) induced anorexia is not influenced by a melanocortin 4 receptor blockage. 1
Behavioral effects of atriopeptin in rats. 1
Melanocortins and feeding behavior 1
CHRONIC ADMINISTRATION OF I-SULPIRIDE AT NON-NEUROLEPTIC DOSES REDUCES THE DURATION OF IMMOBILITY IN EXPERIMENTAL-MODELS OF DEPRESSION-LIKE BEHAVIOR 1
Totale 13.177
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.585
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.585
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021723 0 0 0 0 0 52 111 171 86 190 73 40
2021/2022983 27 141 86 73 29 45 49 34 107 57 212 123
2022/20231.215 159 164 84 128 150 193 24 96 130 9 37 41
2023/2024666 25 42 52 44 139 50 85 83 23 15 63 45
2024/20252.622 92 20 42 184 526 360 276 150 270 95 278 329
2025/20263.178 325 212 551 630 1.135 325 0 0 0 0 0 0
Totale 13.177